US Patent 11712472 Pharmaceutical composition comprising anti-human TSLP receptor antibody
Patent 11712472 was granted and assigned to Upstream Bio on August, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11712472 Pharmaceutical composition comprising anti-human TSLP receptor antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
